InvestorsHub Logo
Followers 59
Posts 11474
Boards Moderated 0
Alias Born 07/16/2006

Re: DewDiligence post# 17983

Sunday, 12/03/2017 4:42:32 PM

Sunday, December 03, 2017 4:42:32 PM

Post# of 20689
While Momenta might release a 8-K regarding the Pfizer situation they really don't follow any certain religion when it comes to providing information.

It has always been said that the insider stock sales have followed a 10b5-1 stock trading plan which is the right way to do it.

Considering the Orencia Failure was announced the morning of the Q3 17' earning call and the Necuparanib Failure was announced the morning of the Q2 16' earnings call it would seem that Momenta releases its info at will.

It also means trading under a 10b5-1 is moot.